ArticleScientific reports2025
Triglyceride-glucose index and its combination with anthropometric obesity indicators are significant predictors of visceral obesity among the Newfoundland population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Triglyceride-Glucose-Waist Circumference Index as a Surrogate Marker for Visceral Obesity: Analysis of NHANES 2011-2018.Obesity science & practice · 2026Article
- Association of Selected Anthropometric Indices With Diabetic Kidney Disease Among Iranian Adults With Diabetes.Endocrinology, diabetes & metabolism · 2026Article
- Simplicity meets accuracy: TyG-Waist as a practical alternative to CVAI for type 2 diabetes prediction in high-risk Chinese adults.BMC endocrine disorders · 2026Article
- Association between the triglyceride-glucose index and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Visceral obesity (VO) is a critical risk factor for metabolic disorders and cardiovascular diseases. Although DXA, CT, or MRI are reliable tools for measuring visceral adiposity, their routine use is limited by cost and accessibility. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has shown potential as a cost-effective predictor of VO in type 2 diabetes mellitus (T2DM). However, its relationship with visceral adiposity in generally healthy populations remains unclear. A total of 2921 healthy adults (825 males, 2096 females) without serious metabolic, cardiovascular, or endocrine diseases were included. Anthropometric measurements (including body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR)) and blood analyses (fasting plasma glucose, triglycerides) were performed. Visceral adipose tissue (VAT) mass and volume were measured using DXA. Logistic regression identified independent factors of VO, defined as VAT mass or volume ≥ 85th percentile by sex. ROC curve analyses assessed the predictive ability of TyG and its related indices. Visceral adiposity increased with ascending TyG quartiles in both sexes, showing a dose-dependent manner. Individuals with VO exhibited higher TyG than those without VO in males (8.95 vs. 8.39) and females (8.81 vs. 8.20). TyG was positively correlated with visceral adiposity and identified as an independent risk factor of VO, with stronger associations in females (OR = 3.512, 95%CI: 2.538-4.861) compared to males (OR = 1.575, 95%CI: 1.002-2.477). ROC analyses showed TyG index had a significant predictive value for VO in males (AUC = 0.733) and females (AUC = 0.791). Combining TyG with BMI, WC, and WHtR, further improved predictive accuracy for VO in females (AUC = 0.930 for TyG-BMI, AUC = 0.929 for TyG-WC, and AUC = 0.926 for TyG-WHtR). TyG index is a significant predictor of VO, particularly in females. Combining TyG with BMI, WC, or WHtR enhances its predictive accuracy, making it a simple, low-cost and valuable screening tool for early identification of individuals at risk of VO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.